Skip to content
Search

Latest Stories

RPS joins UK Health Alliance on Climate Change

The Royal Pharmaceutical Society (RPS) has joined the UK Health Alliance on Climate Change (UKHACC) to pursue its commitment towards climate action within pharmacy and healthcare.

The Alliance, which brings together a number of organisations including many Royal Colleges, Faculties of Health, the British Medical Journal, and the Lancet, coordinates action to amplify the voices of healthcare professionals towards climate change that protect and promote public health.


This comes after the RPS identified sustainability as an urgent issue for attention in 2021, and initiated a range of activities including:

  • Issuing a declaration of a climate emergency
  • Producing a series of policies with recommendations to reduce the environmental impact of medicines and pharmacy practice
  • Committing to fully disinvest from fossil fuels by the end 2022.

On joining the Alliance, RPS president professor Claire Anderson said: “I’m delighted that the RPS is now a full member of UKHACC and to be representing RPS on the Alliance’s Council.

“Through raising awareness of healthcare’s impact on climate change and enabling health professional groups to speak with one voice, the UKHACC has a leading part in reducing the environmental impact of healthcare in the UK. With climate change being such a seismic challenge, collaboration of this kind is vital.

“It’s great that the RPS can now help support the Alliance’s work and bring our expertise in medicines and their impact on the environment to the table."

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less